Geode Capital Management, LLC Vyne Therapeutics Inc. Transaction History

Geode Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.12 - $4.91 $134 - $5,489	-1,118 Reduced 0.25%	449,085 $67,000
Q2 2022 Aug 12, 2022	SELL	$0.37 - $0.71 $7,488 - $14,368	-20,238 Reduced 4.3%	450,203 $175,000
Q3 2021 Nov 12, 2021	BUY	$1.39 - $3.47 $5,340 - $13,331	3,842 Added 0.82%	470,441 $653,000
Q2 2021 Aug 13, 2021	SELL	$3.24 - $6.92 $852,197 - $1.82 Million	-263,024 Reduced 36.05%	466,599 $1.64 Million
Q1 2021 May 12, 2021	BUY	$6.34 - $12.68 $4.63 Million - $9.25 Million	729,623 New	729,623 $4.99 Million

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $187M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.